COLITIS DUE TO CANCER TREATMENT WITH IMMUNE CHECK-POINT INHIBITORS. Radiol Oncol [Internet]. 2024 Jun. 10 [cited 2026 Oct. 27];58(2):179-85. Available from: https://www.radioloncol.com/index.php/ro/article/view/4227